Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation VII: EMR01:30

Methods of Documentation VII: EMR

934
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
934
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

414
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
414
Pharmacovigilance01:19

Pharmacovigilance

1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Methods for Studying Drug Absorption: In situ01:09

Methods for Studying Drug Absorption: In situ

377
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
377
Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

360
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
360
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

642
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
642

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implications of relying on manufacturer patient support programs for access to high-cost specialty and biologic medicines: a critical qualitative study.

BMJ open·2026
Same author

Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages.

Pharmacoepidemiology and drug safety·2026
Same author

How Cancer Online Support Groups Work, for Whom, and in What Circumstances: Realist Review.

Journal of medical Internet research·2026
Same author

Opioid Toxicity Following Concomitant Use of Macrolide Antibiotics with Fentanyl, Hydromorphone, or Oxycodone: A Population-Based Study.

Clinical pharmacology and therapeutics·2026
Same author

Mapping the evidence on the role and impact of plastics in the context of health products and their packaging: A scoping review.

JRSM open·2026
Same author

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients.

Clinical pharmacology and therapeutics·2026

Related Experiment Video

Updated: Sep 28, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K

Understanding Engagement and the Potential Impact of an Electronic Drug Repository: Multi-Methods Study.

Charlene Soobiah1,2, Michelle Phung1, Mina Tadrous1,3

  • 1Institute for Health System Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.

JMIR Formative Research
|March 30, 2022
PubMed
Summary

Centralized drug repositories show potential for improving patient safety, but low adoption rates indicate a need for better integration and data completeness. Optimizing these systems requires aligning them with clinician needs for effective use.

Keywords:
centralized drug repositoryelectronic surveymixed methods

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.0K

Related Experiment Videos

Last Updated: Sep 28, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.0K

Area of Science:

  • Health Informatics
  • Clinical Decision Support
  • Medication Safety

Background:

  • Centralized drug repositories offer potential to reduce medication errors and improve patient care by providing access to dispensed medication data.
  • Understanding the factors influencing the adoption and perceived value of these systems is crucial for optimizing their impact.

Purpose of the Study:

  • To assess the clinical value of a provincial digital health drug repository (DHDR).
  • To identify barriers and enablers to the adoption of the DHDR.
  • To determine which clinician groups would benefit most from the DHDR.

Main Methods:

  • A mixed-methods approach combining a web-based survey and semistructured interviews with Ontario clinicians.
  • Survey data analyzed using descriptive statistics; interview data analyzed using qualitative descriptions.
  • Participants included nurses, physicians, and pharmacists eligible to use the DHDR.

Main Results:

  • Low active usage of the DHDR (24.8%) despite high perceived importance of medication data access.
  • Key barriers to adoption included a cumbersome access process and concerns about data completeness and accuracy.
  • Users found the DHDR satisfactory for secondary information but noted limitations due to missing medication instructions and non-dispensed prescriptions.

Conclusions:

  • Digital drug repositories require optimization to align with clinician needs for enhanced value and adoption.
  • Integration with point-of-care systems, comprehensive data, and streamlined onboarding are essential for meaningful clinical use.
  • Accessible electronic drug information can improve healthcare efficiency and reduce medication errors.